LSE:HLN (Haleon plc)
About HLN
Haleon (NYSE: HLN) is a leading global consumer health company with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, Therapeutic Skin Health, and Wellness. Built on trusted science, innovation, and deep human understanding, Haleon's U.S. brands include Abreva, Advil, Benefiber, Centrum, Emergen-C, Excedrin, Flonase, Gas-X, Nexium, Nicorette, Parodontax, Polident, Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS, Voltaren, and more.
Haleon plc (LSE: HLN) Latest News
Investing Articles
Is the Haleon share price cheap under £3 ahead of earnings?
Investing Articles
3 unmissable FTSE 100 stocks to buy as the pound crashes!
Investing Articles
Is the Haleon share price slide a buying opportunity?
Investing Articles
Could this be the best stock to buy for big autumn gains?
Investing Articles
Is now a unique buying opportunity for Haleon shares?
Investing Articles
The Haleon share price continues to fall! Is it now a prime buying opportunity?
Investing Articles
Here’s why GSK and Haleon shares have tanked this week
Investing Articles
Is the Haleon share price set to soar? Its directors certainly seem confident
Investing Articles
Should I snap up Haleon shares at £3?
Investing Articles
Should I buy Haleon shares or GSK after the demerger?
Investing Articles
Should I buy Haleon shares to double my money, tax-free?
Investing Articles
Will the Haleon share price hit £2 or £4 first?
1❯